Diseases obsessive compulsive disorder

Olanzapine has been compared with placebo in different mental disorders, including the non-approved indications of psychotic depression, Alzheimer s disease, obsessive-compulsive disorder, and alcohol dependence. 

HT has been implicated in the etiology of numerous disease states, including depression, anxiety, social phobia, schizophrenia, obsessive compulsive disorders,... 

A considerable number of tricyclic antidepressants have been developed in the past, although with slight differences in their pharmacological activities, ah with similar efficacy. They are primarily indicated for the treatment of endogenous depression. However this does not exclude efficacy in patients in whom the depression is associated with organic disease or in patients with reactive depression or depression combined with anxiety. They may also benefit patients during the depressive phase of manic-depressive disorder. For some also efficacy has been claimed in panic states, phobic disorders, and in obsessive-compulsive disorders. 

Although genetic influences on the dynamics of drug response have been studied in a wide range of disorders, most of the studies have been carried out in only the past few years. Disorders and behaviors studied include Alzheimer s disease, schizophrenia, depression, suicide, anxiety, obsessive-compulsive disorder (OCD), substance abuse, smoking, and alcoholism. Across these disorders, however, there has been a focus on only a handful of neuroeffector systems. These include apolipoprotein and the cholinergic system (in Alzhei-... 

Cummings, J.L. and Cunningham, K. (1992) Obsessive-compulsive disorder in Huntington s disease. Biol Psychiatry 31 263-270. 

Cummings, J.L. and Cunningham, K. (1992) Obsessive-compulsive disorder in Huntington s disease. Biol Psychiatry 31 263-270. Denckla, M.B. (1989) Neurological examination. In Rapoport, J.L., ed. Obsessive-Compulsive Disorder in Children and Adolescents. Washington, DC American Psychiatric Press, pp. 107-118. Douglass, H.M., Moffit, T.E., Dar, R., McGee, R., and Silva, P. (1995) Obsessive-compulsive disorder in a birth cohort of 18 year olds prevalence and predictors. / Am Acad Child Adoles Psychiatry 34 1424-1431. 

Golden RN, Morris JE, Sack DA Combined lithium-tricyclic treatment of obsessive-compulsive disorder. Biol Psychiatry 23 181-185, 1988 Goldenberg G, Lang W, Podreka 1, et al Are cognitive deficits in Parkinson s disease caused by frontal lobe dysfunction Journal of Psychophysiology 4 137-144, 1990 Goldgaber D, Harris HW, Hla T Interleukin-1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc Natl Acad Sci U S A 86 7606-7610, 1989... 

Greist JH, Jenike MA, Robinson DS, et al Efficacy of fluvoxamine in obsessive-compulsive disorder results of a multicentre, double-bhnd, placebo-controlled trial. European Journal of Clinical Research 7 195-204, 1995c Griffin WST, Stanley LC, Ling C, et al Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci U S A 86 7611-7615, 1989... 

Anxiety, depression, insomnia, different types of phobia, obsessive-compulsive disorder, post-traumatic stress disorder, panic attacks, acute stress disorder. It is also related to chronic diseases, such as anemia, and diseases of the heart and lung. 

Hu Po is sweet and neutral, and enters the blood level of the Heart and Liver. It is particularly effective in sedating the Shen and removing congealed blood. It treats palpitations and restlessness due to blood stagnation. It is used in treating severe and persistent heart and mental disorders such as coronary heart disease, phobia, obsessive-compulsive disorder and manic depression. 

Mouatt-Prigent, A., Karlsson, J.O., Agid, and Hirsch E.C., 1996, Increased M-calpain expression in the mesencephalon of patients with Parkinson s disease but not in other neurodegenerative disorders involving the mesencephalon a role in nerve cell death, Neuroscience, 73, 979—987 Mundo, E., Soldati, L., Bellodi, L., Bianchi, G., 1997, The calpain-calpastatin system in obsessive-compulsive disorder, Biol. Psychiatry 42, 228—229... 

Although neuroticism is not a disease per se, it predisposes individuals to anxiety disorders (12, 13). Neuroticism is a vulnerability factor for all forms of anxiety (14-16). A system established by the Diagnostic and Statistical Manual for Psychiatric Disorders in the United States, currently in its 4th edition (DSM-IV) text revision (TR) (American Psychiatric Association, 2000), sets the boundary at which a particular level of behavior becomes an anxiety disorder—a level often based on the number and the duration of symptoms. DSM is a categorical system based on the qualitative separation of disease states from the state of well-being. The DSM-IVTR category of anxiety disorders currently includes generalized anxiety disorder (GAD), simple phobia, posttraumatic stress disorder (PTSD), panic disorder, social phobia, and obsessive compulsive disorder (OCD) as discrete anxiety disorders. The International Classification of Diseases-10 (IC-10) is a similar system, but it is less frequently used in research (17). 

Basal ganglia Controls aspects of motor behavior Neuronal pathways connecting limbic system and prefrontal lobes Parkinson s disease, antipsychotic medication side effects (extrapyramidal symptoms (EPS)) Obsessive-compulsive disorder... 

---